Ambev details September 2025 restricted share delivery

Ambev S.A. filed a report detailing its own transactions in company securities for September 2025 under Brazilian CVM Instruction 358.

Rhea-AI Filing Summary

Ambev S.A. filed a report detailing its own transactions in company securities for September 2025 under Brazilian CVM Instruction 358. The company used treasury shares to fulfill a delivery of restricted shares, moving 146,923 common shares out of treasury at a reference price of R$ 12,30 per share, for a stated volume of R$ 1,807,152.90. As a result, Ambev’s treasury position in common shares changed from 169,352,327 at the beginning of the month to 169,205,404 at month-end, with no ADRs held in treasury.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Ambev (ABEV) report in this October 2025 Form 6-K?

Ambev S.A. reported its September 2025 transactions in its own securities under Article 11 of CVM Instruction 358, showing a delivery of restricted shares using treasury stock and updated beginning and ending treasury share balances.

How many Ambev (ABEV) shares were delivered as restricted shares in September 2025?

Ambev delivered 146,923 common shares as restricted shares in September 2025, according to the transaction labeled “Delivery of restricted shares.”

What were Ambev (ABEV) treasury share balances before and after the September 2025 transaction?

The balance of Ambev common shares held in treasury was 169,352,327 at the beginning of September 2025 and 169,205,404 at the end of the month, reflecting the restricted share delivery.

At what price and volume were Ambev (ABEV) restricted shares recorded in September 2025?

The restricted share delivery of 146,923 common shares was recorded at a price of R$ 12,30 per share and a total stated volume of R$ 1,807,152.90.

Did Ambev (ABEV) report any ADR treasury activity for September 2025?

No activity in ADRs was reported; Ambev showed 0 ADRs in treasury at both the initial and final balances for September 2025.

Who signed the Ambev (ABEV) September 2025 Form 6-K report?

The report was signed on behalf of Ambev S.A. by Guilherme Fleury de Figueiredo Ferraz Parolari, the Chief Financial and Investor Relations Officer.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/07/2025 - 04:58 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

For the month of October, 2025

Commission File Number 1565025

AMBEV S.A.

(Exact name of registrant as specified in its charter)

AMBEV S.A.

(Translation of Registrant's name into English)

Rua Dr. Renato Paes de Barros, 1017 - 3rd Floor
04530-000 São Paulo, SP
Federative Republic of Brazil

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F. 

Form 20-F ___X___ Form 40-F _______

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. 

Yes _______ No ___X____

INDIVIDUAL FORM

Article 11 - CVM Instruction # 358/2002

In September 2025:

(X ) the only transactions with securities and derivatives were those presented below, in compliance with Article 11 - CVM Instruction # 358/2002.⁽¹⁾

( ) no securities and derivatives operations took place, in compliance with Article 11 - CVM Instruction # 358/2002, with my securities and derivatives positions as follows.

Company Name: Ambev S.A.

Name: Ambev S.A.

CPF/CNPJ: 07.526.557/0001-00

Qualification: Outstanding Shares in Treasury

Initial Balance

Securities / Derivatives

Securities Characteristics (2)

Quantity

Shares

Common

169,352,327

ADR

Common

0.00

Transactions in the month

Securities / Derivatives

Securities Characteristics (2)

Intermediary

Operation

Day

Quantity

Price

Volume (R$)(3)

Shares

Common

Direct with company

Delivery of restricted shares

02

146,923

12,30

1,807,152.90

Final Balance

Securities / Derivatives

Securities Characteristics (2)

Quantity

Shares

Common

169,205,404

ADR

Common

0

(1) When filling in the form, delete the lines that do not have any information, If there is no acquisition/change in the position of any person in relation to Article 11 - CVM Instruction # 358/2002, send a statement with that information,

(2) Issue/Series, convertibility, simple, term, guaranties, type/class, among others,

(3) Quantity multiplied by price,

(*) Each ADR is equivalent to 1 (one) share,

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: October 7, 2025

	AMBEV S.A.
	By:	/s/ Guilherme Fleury de Figueiredo Ferraz Parolari
		Guilherme Fleury de Figueiredo Ferraz Parolari Chief Financial and Investor Relations Officer